U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754617) titled 'Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis: an RCT' on Aug. 04.
Brief Summary: The goal of this clinical trial is to learn if treating individuals living in Uganda who have liver fibrosis (scarring) due to schistosomiasis would benefit from more frequent treatment with drug praziquantel. This drug is already approved to treat schistosomiasis and is used globally. The study will include individuals who have schistosomiasis and some degree of liver fibrosis. The main questions it aims to answer are:
1. Does treating people three times per year as compared to once per year as currently recommended impr...